A bipartisan coalition of State Attorneys General have asked the US Department of Health and Human Services to step up efforts to increase the supply of the COVID-19 drug remdesivir as well as lowering the cost of the medication, USA Today reports.
Led by California Attorney General Xavier Becerra and Louisiana Attorney General Jeff Landry, the state officials have urged DHHS, the Federal Drug Administration and National Institutes of Health to make it easier for other manufacturers to license the drug formula to boost the supply of the medication.
The manufacturer of the drug, Gilead Sciences, charges more than $3,000 for a five day therapeutic treatment of the medication, which has been shown in studies to help abate coronavirus.